The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world settingBillard Karine, Célèste Lebbé, Bastien Oriano et al.|British Journal of Dermatology|2024Cited by 4